Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade

(2013) A. M. Tortorano et al.   INFECTION

Candidemia by Species of the Candida parapsilosis Complex in Children’s Hospital: Prevalence, Biofilm Production and Antifungal Susceptibility

(2013) Luciana da Silva Ruiz et al.   MYCOPATHOLOGIA

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

(2012) Michael Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Retrospective Analysis of Epidemiology and Prognostic Factors for Candidemia at a Hospital in China, 2000^|^ndash;2009

(2012) Xiao-Bing Zhang et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

(2012) J. Peman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Routine Identification of Medical Fungi by the New Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight System with a New Time-Effective Strategy

(2012) Xavier Iriart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of theCandida parapsilosiscomplex in East China: species distribution differs among cities

(2012) Yi P. Ge et al.   MEDICAL MYCOLOGY

Epidemiology ofCandidablood stream infections in patients with hematological malignancies or solid tumors

(2012) Janina Zirkel et al.   MEDICAL MYCOLOGY

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

(2011) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK

(2011) I. Das et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Direct MALDI-TOF Mass Spectrometry Assay of Blood Culture Broths for Rapid Identification of Candida Species Causing Bloodstream Infections: an Observational Study in Two Large Microbiology Laboratories

(2011) Teresa Spanu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008

(2011) M. Ortega et al.   JOURNAL OF HOSPITAL INFECTION

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer

(2011) Maria N. Chitasombat et al.   JOURNAL OF INFECTION

Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK

(2011) C. Chalmers et al.   MYCOSES

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy

(2011) Matteo Bassetti et al.   PLoS One

Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identification of Yeasts Is Contingent on Robust Reference Spectra

(2011) Angie Pinto et al.   PLoS One

Secular trends of candidemia in a tertiary care hospital

(2010) Thiago Zinsly Sampaio Camargo et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Epidemiology of invasive candidiasis

(2010) Maiken C Arendrup   Current Opinion in Critical Care

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology ofcandidabloodstream infections in a tertiary care institute in India

(2009) A Kothari et al.   Indian Journal of Medical Microbiology

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

(2009) S. A. Messer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

(2009) D. J. Diekema et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES